Wells Fargo raised the firm’s price target on Inspire Medical (INSP) to $198 from $187 and keeps an Equal Weight rating on the shares. The firm notes Inspire reported Q3 sales/EPS ahead of Street expectations and raised 2024 sales/EPS guidance. Q4 sales outlook is slightly softer due to hurricane/IV shortage headwinds, Wells adds.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on INSP:

• Inspire Medical Reports Strong Q3 Growth and Raises Outlook

• Inspire Medical Systems Sees Strong Q3 Growth in 2024

• Inspire Medical raises FY24 EPS view to $1.20-$1.40 from 60c-80c

• Inspire Medical reports Q3 EPS 60c, consensus 8c

• Inspire Medical (INSP) Q3 Earnings Cheat Sheet